Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

IDEA Collider: Innovation & Asymmetric Learning in Pharma

IDEA Collider: Innovation & Asymmetric Learning in Pharma artwork

AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.

Oct 7, 202641 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President, Strategic Consulting & Analytics Business Unit at SAI. Together, they explore how artificial intelligence and synthetic behavioral modeling are transforming pharmaceutical market research and insight generation. For decades, market research operated under a strict constraint: you could choose two between speed, price, and quality, but never all three. Rebecca and Kwame discuss how synthetic user technology breaks this triangle, allowing biopharma teams to generate high-quality qualitative insights rapidly and cost-effectively. Kwame breaks down the architecture behind synthetic users - defining them as an abstraction of brain architecture that replicates human emotional responses, cognitive biases, and system 1 behaviors rather than striving for super intelligence. Rebecca shares real-world case studies in rare diseases, competitive simulation workshops, and creative concept testing where synthetic personas achieved over 90% parity with live human respondents. Tune in to discover how synthetic research is empowering healthcare leaders to make faster, higher-confidence decisions across the thousands of choices required to bring a medicine to market. Keep up with the Guests Rebecca Gould's LinkedIn: https://www.linkedin.com/in/rebecca-gould-b30b73/ Kwame Ferreira's LinkedIn: https://www.linkedin.com/in/kwame-ferreira-1b06a31/ Keep up with Rick Ritacco: LinkedIn: https://www.linkedin.com/in/rritacco/ Follow IDEA Pharma On; Website: https://www.ideapharma.com/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. ESMO 2026 Preview: Key studies that could fundamentally change the oncology landscape.

    Oct 22, 202642 minAudio

    In this episode of the IDEA Collider podcast, Alex Gray, Chief Medical Officer at SAI & IDEA Pharma, John Barry, Executive Vice President at SAI, and Tom Brockbank, Senior Consultant at IDEA Pharma, look ahead to ESMO...

    Credit the people on this episode

  2. The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution: Part II

    Sep 14, 202636 minAudio

    Welcome back to the IDEA Collider podcast. In this second instalment of our future of immuno-oncology series, Alex Gray is joined by colleagues David Radwaner and Tom Brockbank to discuss what lies ahead for cancer...

    Credit the people on this episode

  3. Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory Strategy

    Jul 16, 202649 minAudio

    Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and COO of Immunic, to discuss the rapidly evolving landscape of Multiple Sclerosis (MS) treatment. For 30...

    Credit the people on this episode

  4. The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.

    Jul 1, 202650 minAudio

    Welcome to a special edition of IDEA Collider’s "Deep Medicine" series. In this episode, host Alex Gray sits down with Athina Metaxa, a consultant at IDEA Pharma and psychedelic research expert, to discuss the rapidly...

    Credit the people on this episode

  5. The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning

    Jun 24, 202643 minAudio

    Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior expert at IDEA Pharma with a PhD from Oxford and decades of experience translating complex scientific concepts...

    Credit the people on this episode